eMagin (NYSE:EMA – Get Free Report) had its price objective decreased by stock analysts at Barclays from $55.00 to $53.00 in a research report issued to clients and investors on Monday,Benzinga reports. The brokerage currently has an “equal weight” rating on the stock. Barclays‘s target price would suggest a potential upside of 4.38% from the company’s current price.
Several other research firms have also recently issued reports on EMA. Wall Street Zen upgraded eMagin from a “strong sell” rating to a “sell” rating in a research report on Saturday, April 18th. Weiss Ratings cut shares of eMagin from a “buy (b)” rating to a “buy (b-)” rating in a research note on Thursday, July 2nd. One analyst has rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $60.50.
Check Out Our Latest Research Report on eMagin
eMagin Stock Down 0.1%
Hedge Funds Weigh In On eMagin
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. State of Tennessee Department of Treasury purchased a new stake in shares of eMagin in the second quarter valued at about $7,749,000. Russell Investments Group Ltd. raised its position in shares of eMagin by 22.5% during the 4th quarter. Russell Investments Group Ltd. now owns 131,852 shares of the company’s stock worth $6,506,000 after purchasing an additional 24,241 shares during the last quarter. Rathbones Group PLC lifted its stake in eMagin by 0.3% in the 1st quarter. Rathbones Group PLC now owns 58,900 shares of the company’s stock valued at $3,043,000 after buying an additional 200 shares in the last quarter. Venturi Wealth Management LLC grew its holdings in eMagin by 12.1% during the 1st quarter. Venturi Wealth Management LLC now owns 8,111 shares of the company’s stock valued at $421,000 after buying an additional 877 shares during the last quarter. Finally, Versant Capital Management Inc grew its holdings in eMagin by 15.0% during the 2nd quarter. Versant Capital Management Inc now owns 7,396 shares of the company’s stock valued at $392,000 after buying an additional 963 shares during the last quarter.
eMagin Company Profile
eMagin Corporation engages in the design, develop, manufacture, and market of organic light-emitting diode (OLED) miniature displays on-silicon micro displays, virtual imaging products that utilize OLED micro displays, and related products in the United States and internationally. It offers super video graphics array (SVGA) + OLED micro displays; digital SVGA OLED-XL; super extended graphics array OLED-XL/XLS; video graphics array OLED-XL; and widescreen ultra-extended graphics array OLED-XL. The company also provides design reference kits, which include a micro display and associated electronics to help original equipment manufacturers (OEMs) to evaluate micro display products; near-eye virtual imaging modules that incorporate its OLED-on-silicon micro displays with its lenses and electronic interfaces for integration into OEM products; prism optics, a molded plastic prism lens that permits its AMOLED micro displays to provide realistic images that can be viewed for extended periods with reduced eye-fatigue; and driver boards.
Recommended Stories
- Five stocks we like better than eMagin
- AI Data Centers Are Splitting Winners From Pretenders in Infrastructure Stocks
- 3 of the Market’s Most-Upgraded Tech Stocks Right Now
- Albemarle’s Blowout Quarter Shows Why Lithium Still Matters
- Can DICK’S Turn Foot Locker Into a Winner?
Receive News & Ratings for eMagin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for eMagin and related companies with MarketBeat.com's FREE daily email newsletter.
